2. Academic Validation
  3. Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation

Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation

  • Eur J Med Chem. 2025 Dec 15:304:118488. doi: 10.1016/j.ejmech.2025.118488.
Xu-Bin Ma 1,  Kai Sun 1,  Yuan-Yuan Liu 1,  Liang Wang 1,  Chen-Ran Lu 1,  Mo-Han Li 1,  Zhuang-Zhuang Li 1,  Hong-Min Liu 2,  Yi-Chao Xu 3
Affiliations

Affiliations

  • 1 Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Henan Province Key Laboratory of Small Molecule Drug Discovery and Applied Research, School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.
  • 2 Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Henan Province Key Laboratory of Small Molecule Drug Discovery and Applied Research, School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China. Electronic address: liuhm@zzu.edu.cn.
  • 3 Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Henan Province Key Laboratory of Small Molecule Drug Discovery and Applied Research, School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China. Electronic address: xuyc2017@zzu.edu.cn.
PMID: 41418743 DOI: 10.1016/j.ejmech.2025.118488
Abstract

USP7 has been reported to promote Cancer progression through removing ubiquitin from various substrates, making it a target for Cancer therapy. To now, several USP7 proteolysis-targeting chimeras (PROTACs) have been reported, and USP7 inhibitors used in USP7 PROTACs all feature tert-hydroxypiperidinol scaffold. In this study, we firstly designed and synthesized a panel of novel USP7 PROTACs with USP7 Inhibitor containing thienopyridine, and identified D16 as a potent and selective USP7 Degrader. Mechanistic investigation with specific inhibitors revealed that D16 induced USP7 degradation by binding to USP7 and E3 Ligase CRBN. Proteomics analysis showed that D16 selectively decreased the expression of USP7 rather than Other USPs. Moreover, treatment of D16 suppressed cell migration of upper gastrointestinal (UGI) Cancer cells with minor anti-proliferative activity. Our findings highlight that D16 may support as a promising lead compound for metastatic UGI Cancer treatment.

Keywords

Cancer metastasis; Thienopyridine; UGI cancer; USP7 degraders.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z